Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Jurgis Bekepuris who wrote (33376)	1/29/2009 11:43:34 AM
From: Oblomov	Read Replies (1) \| Respond to of 78655

I can understand why it might not be your style of investment. It certainly isn't a value stock in the typical sense of that term (so I'll shut up about it on this thread after this post). The company made some mistakes in 2004-5 that resulted in losses in 2004-2006; most prominent is that they followed the terrible advice from WS analysts and tried to run the company by the 90s pharma model (which the big pharma companies are abandoning, but slowly): too much DTC for Lunesta and a big sales force. They have brought on a new middle and upper-level management team on their marketing side that is excellent, and whose vision of an efficient marketing culture is starting to come to fruition. So I hold it as a turnaround play, not without its risks.